BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.480,29 PKT -6,17 PKT -0,42 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
14.02.12 Roche neutral Citigroup Corp.
14.02.12 Geberit halten Öko Invest
14.02.12 UBS overweight HSBC
14.02.12 UBS overweight HSBC
13.02.12 Zurich Insurance neutral UBS AG
13.02.12 ABB (Asea Brown Boveri) buy ING
13.02.12 UBS neutral UBS AG
13.02.12 Zurich Insurance buy ING
10.02.12 UBS halten Independent Research GmbH
10.02.12 UBS underperform Exane-BNP Paribas SA
10.02.12 UBS neutral Nomura
10.02.12 UBS hold Société Générale Group S.A. (SG)
10.02.12 UBS sector perform RBC Capital Markets
10.02.12 Swisscom buy Société Générale Group S.A. (SG)
09.02.12 Zurich Insurance neutral J.P. Morgan Cazenove
09.02.12 UBS hold Commerzbank Corp. & Markets
09.02.12 UBS outperform Macquarie Research
09.02.12 UBS sell Deutsche Bank AG
09.02.12 UBS outperform RBC Capital Markets
08.02.12 Holcim hold Deutsche Bank AG
08.02.12 Holcim hold Deutsche Bank AG
08.02.12 Zurich Insurance buy Deutsche Bank AG
08.02.12 UBS hold Société Générale Group S.A. (SG)
08.02.12 UBS buy Nomura
08.02.12 Roche halten Hamburger Sparkasse AG (Haspa)
08.02.12 UBS overweight Morgan Stanley
08.02.12 UBS verkaufen Independent Research GmbH
07.02.12 UBS neutral WestLB AG
07.02.12 Zurich Insurance neutral J.P. Morgan Cazenove
07.02.12 UBS neutral Sarasin Research
07.02.12 Novartis underperform Banc of America Securities-Merrill Lynch
07.02.12 ABB (Asea Brown Boveri) hold Société Générale Group S.A. (SG)
07.02.12 Zurich Insurance buy Société Générale Group S.A. (SG)
07.02.12 Julius Bär buy Sarasin Research
07.02.12 ABB (Asea Brown Boveri) outperform Exane-BNP Paribas SA
06.02.12 Roche buy Banc of America Securities-Merrill Lynch
06.02.12 ABB (Asea Brown Boveri) neutral UBS AG
06.02.12 UBS hold Société Générale Group S.A. (SG)
03.02.12 Roche outperform Exane-BNP Paribas SA
03.02.12 Holcim hold Deutsche Bank AG